These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Nov. 6 through Nov. 12, 2025. Source: VerityData

Activist Filings

Pacira BioSciences $(PCRX)$ Doma Perpetual Capital Management raised its stake in the pain-management biopharmaceutical company to 2,936,794 shares. Doma did so through the purchase of 238,176 Pacira BioSciences shares from Sept. 10 through Oct. 7 at prices ranging from $23.77 to $26.50, on average. On Nov. 10, Doma issued an open letter to Pacira's board of directors, advocating for the company to hire bankers and conduct a formal sales process for the business. The letter cites "management's unrelenting underperformance, out-of-control spending, and lack of prudent financial control."

Following the latest purchases, Doma Perpetual Capital Management owns a 6.8% stake in Pacira BioSciences' outstanding stock. Shares of Pacira have gained roughly 31% in value in 2025.

Decreases in Holdings

Garrett Motion (GTX) Cyrus Capital Partners reduced its stake in the vehicle-parts maker to 14,104,901 shares. Cyrus Capital did so through the sale of 4,542,226 Garrett Motion shares from Oct. 16 through Nov. 5 at per share prices ranging from $12.27 to $17.54.

Following the latest sales, Cyrus Capital continues to own 7.3% of Garrett Motion's outstanding stock. Shares of Garrett Motion have gained roughly 94.2% in value since the beginning of this year.

Sionna Therapeutics (SION) RA Capital Management lowered its stake in the clinical-stage biopharmaceutical company to 10,071,712 shares. RA Capital Management did so through the sale of 373,610 Sionna Therapeutics shares from Oct. 24 through Oct. 28 at per share prices ranging from $39.50 to $39.81.

Following the latest sales, RA Capital Management continues to own 22.6% of Sionna Therapeutics' outstanding stock. Shares of Sionna Therapeutics have gained roughly 45.1% in value in 2025.

Bitdeer Technologies Group (BTDR) Tether Holdings lowered its stake in the blockchain specialist to 30,356,531 shares. The cryptocurrency company sold 7,720,158 Bitdeer Technologies shares from Sept. 12 through Oct. 20 at per share prices ranging from $16.07 to $27.16.

Following the latest sales, Tether Holdings owns 14.3% of Bitdeer Technologies' outstanding stock. Shares of Bitdeer have lost approximately 39.4% of their value in 2025.

Concentrix $(CNXC)$ Impactive Capital reduced its stake in the customer experience services provider to 3,066,213 shares. Impactive Capital did so through the sale of 1,308,912 Concentrix shares from Oct. 2 through Nov. 7 at per share prices ranging from $34.61 to $48.66.

Following the latest sales, Impactive Capital continues to own 4.9% of Concentrix's outstanding stock, placing Impactive below the 5% threshold that would require it to report further sales. Shares of Concentrix have lost roughly 18.8% of their value since the beginning of this year.

Email: editors@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

November 14, 2025 18:00 ET (23:00 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.